Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherThis Month in JNM

This Month in JNM

Journal of Nuclear Medicine February 2006, 47 (2) 7a-8a;
  • Article
  • Info & Metrics
  • PDF
Loading

Uren reviews the relatively brief history and current clinical significance of the sentinel lymph node biopsy technique and looks to the literature for answers to key questions about the efficacy and safety of this increasingly important approach.
Page 191

Reilly surveys the development of pretargeting strategies using monoclonal antibodies and, previewing an article in this issue of JNM, outlines the promise and challenges of pretargeting using bispecific antibodies and radiolabeled haptens.
Page 196

Figure

Meyer and colleagues assess the application of voxelwise graphical analysis to the generation of high-quality parametric images of total volume of distribution of the novel PET tracer 18F-CPFPX in imaging of cerebral adenosine receptors.
Page 200

Kim and colleagues research the reproducibility and reliability of 11C-DASB parametric imaging of binding potential and relative blood flow for PET studies of serotonin transporters in humans.
Page 208

Ciarmiello and colleagues report on findings, including PET data, indicating that white-matter volume loss may precede gray-matter atrophy long before onset of clinical symptoms of Huntington's disease and that this loss may be associated with neuronal dysfunction in early disease.
Page 215

Ezziddin and colleagues explore predisposing factors for uptake of both 111In-pentetreotide and 123I/131I-MIBG in scintigraphy of patients with metastatic gastroenteropancreatic endocrine tumors, with special reference to new World Health Organization tumor classifications.
Page 223

Rossi and colleagues present findings from an observational multicenter trial of a standardized sentinel lymph node biopsy protocol in patients with primary cutaneous melanoma.
Page 234

Fang and colleagues investigate correlations between serum interleukin-2 and tumor necrosis factor-α levels and response to 89SrCl2 as palliative therapy in patients with painful bone metastases.
Page 242

Kraeber-Bodéré and colleagues report on the results of a phase I study of the safety, targeting, and antitumor efficacy of pretargeted radioimmunotherapy using an anti-carcinoembryonic antigen bispecific antibody and a radiolabeled hapten in patients with nonmedullary or medullary thyroid carcinoma.
Page 247

Figure

Pauleit and colleagues compare the diagnostic capabilities of 18F-FET and 18F-FDG PET in patients with squamous cell carcinoma of the head and neck, including the ability to differentiate between tumor and inflammation.
Page 256

Kwee and colleagues assess 18F-fluorocholine uptake in malignant and benign areas of the prostate at 2 time points to determine the suitability of delayed or dual-phase 18F-fluorocholine PET for localizing malignancy.
Page 262

Padmanabhan and colleagues evaluate radionuclide and optical methods to measure changes in human telomerase reverse transcriptase gene expression in tumor cells before and after 5-fluorouracil treatment.
Page 270

Figure

Zenz and colleagues study the incidence and clinical picture of bone marrow transplantation nephropathy in patients receiving a radiolabeled anti-CD66 antibody before allogeneic stem cell transplantation.
Page 278

Even-Sapir and colleagues report on the comparative abilities of 99mTc-MDP planar bone scintigraphy, SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT in the detection of bone metastases in patients with high-risk prostate cancer.
Page 287

Allen-Auerbach and colleagues investigate the incidence of missed pulmonary micronodules on PET/CT studies acquired during shallow breathing and discuss the implications of their findings for comprehensive cancer staging.
Page 298

Heiss and Herholz present an in-depth review of brain receptor imaging and highlight ligands and receptors that are already in clinical use and are likely to influence new drug development and enhance highly specific neurologic imaging.
Page 302

Figure

Slifstein and colleagues perform whole-body radiation dosimetry of 11C-raclopride in healthy humans to derive the maximum allowable single-study dose under U.S. federal regulations and compare this to the dose range currently used in PET research studies.
Page 313

Garcia and colleagues describe a novel system developed to assist physicians in detecting renal obstruction in patients undergoing pre- and postfurosemide 99mTc-MAG3 scanning.
Page 320

Kim and colleagues report on a factor analysis technique for extracting blood input function and myocardial time–activity curve from dynamic small-animal PET images of the rodent heart as a method for overcoming imaging problems caused by cardiac motion.
Page 330

Maskali and colleagues assess a novel gated SPECT imaging technique for predicting and quantifying variable left ventricular remodeling in a rat infarct model.
Page 337

Figure

Tipre and colleagues explore in vivo inhibition of defluorination of 18F-FCWAY in a rat model to improve use of the tracer in PET assessment of brain regional 5-HT1A receptor densities.
Page 345

Figure

Gunn and colleagues investigate whether somatostatin receptor (sst) gene expression is upregulated in vitro by exposure of sst-expressing cells to low- or high-dose octreotide therapy over varying times.
Page 354

Liu and colleagues detail initial studies of the mechanism of intracellular antisense targeting through measurements of in situ transcription, immunofluorescence, reverse transcription polymerase chain reaction, 32P-labeled uridine-5′-triphosphate incorporation, accumulations of 99mTc-labeled DNAs, and messenger RNA transcription.
Page 360

ON THE COVER

In this illustration of the possible effect of different numbers of radiotracer injections (X) on the outcome of lymphoscintigraphy, arrows represent lymphatic flow. A single injection (left) might enter only central lymphatic vessels, missing those potentially containing malignant cells. Moreover, the large volume of tracer used might cause nonsentinel nodes to be detected. Multiple injections (right) might enter peripheral lymphatic vessels and thus detect sentinel nodes containing metastatic melanoma cells. Moreover, the small volume of tracer used might help to avoid detection of second-tier nodes.

Figure

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 47 (2)
Journal of Nuclear Medicine
Vol. 47, Issue 2
February 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
This Month in JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
This Month in JNM
Journal of Nuclear Medicine Feb 2006, 47 (2) 7a-8a;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
This Month in JNM
Journal of Nuclear Medicine Feb 2006, 47 (2) 7a-8a;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • Sentinel Lymph Node Biopsy in Melanoma
  • Radioimmunotherapy of Solid Tumors: The Promise of Pretargeting Strategies Using Bispecific Antibodies and Radiolabeled Haptens
  • 18F-CPFPX PET: On the Generation of Parametric Images and the Effect of Scan Duration
  • PET Imaging of Serotonin Transporters with [11C]DASB: Test–Retest Reproducibility Using a Multilinear Reference Tissue Parametric Imaging Method
  • Brain White-Matter Volume Loss and Glucose Hypometabolism Precede the Clinical Symptoms of Huntington's Disease
  • Factors Predicting Tracer Uptake in Somatostatin Receptor and MIBG Scintigraphy of Metastatic Gastroenteropancreatic Neuroendocrine Tumors
  • The Impact of Lymphoscintigraphy Technique on the Outcome of Sentinel Node Biopsy in 1,313 Patients with Cutaneous Melanoma: An Italian Multicentric Study (SOLISM–IMI)
  • Serum Concentrations of IL-2 and TNF-α in Patients with Painful Bone Metastases: Correlation with Responses to 89SrCl2 Therapy
  • Targeting, Toxicity, and Efficacy of 2-Step, Pretargeted Radioimmunotherapy Using a Chimeric Bispecific Antibody and 131I-Labeled Bivalent Hapten in a Phase I Optimization Clinical Trial
  • 18F-FET PET Compared with 18F-FDG PET and CT in Patients with Head and Neck Cancer
  • Localization of Primary Prostate Cancer with Dual-Phase 18F-Fluorocholine PET
  • Visualization of Telomerase Reverse Transcriptase (hTERT) Promoter Activity Using a Trimodality Fusion Reporter Construct
  • Bone Marrow Transplantation Nephropathy after an Intensified Conditioning Regimen with Radioimmunotherapy and Allogeneic Stem Cell Transplantation
  • The Detection of Bone Metastases in Patients with High-Risk Prostate Cancer: 99mTc-MDP Planar Bone Scintigraphy, Single- and Multi-Field-of-View SPECT, 18F-Fluoride PET, and 18F-Fluoride PET/CT
  • Standard PET/CT of the Chest During Shallow Breathing Is Inadequate for Comprehensive Staging of Lung Cancer
  • Brain Receptor Imaging
  • Biodistribution and Radiation Dosimetry of the Dopamine D2 Ligand 11C-Raclopride Determined from Human Whole-Body PET
  • RENEX: An Expert System for the Interpretation of 99mTc-MAG3 Scans to Detect Renal Obstruction
  • Minimally Invasive Method of Determining Blood Input Function from PET Images in Rodents
  • Initial Infarct Size Predicts Subsequent Cardiac Remodeling in the Rat Infarct Model: An In Vivo Serial Pinhole Gated SPECT Study
  • PET Imaging of Brain 5-HT1A Receptors in Rat In Vivo with 18F-FCWAY and Improvement by Successful Inhibition of Radioligand Defluorination with Miconazole
  • In Vitro Modeling of the Clinical Interactions Between Octreotide and 111In-Pentetreotide: Is There Evidence of Somatostatin Receptor Downregulation?
  • Initial Mechanistic Studies of Antisense Targeting in Cells
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire